Han Qin

Verified profile

Venture Capital, Corporate Venture Capital, Investor · China

Han Qin is a venture capital investor and corporate venture capital investor based in China. They invest in Genetics, Women Founded, Intelligent Systems and Energy, typically at the Seed stage. Their portfolio includes FRX Polymers, Heliatek, Essentium and BigRep and 41 other companies.

Investment stages

Industries

Portfolio companies (45)

Similar investors in Genetics

  • Fei ChenVerified

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics

    Contact details available

  • Wanyi Zhao

    Venture Capital, Corporate Venture Capital, Investor · China

    SeedGeneticsWomen FoundedIntelligent SystemsEnergy

    Portfolio: FRX Polymers, Heliatek

    Contact details available

  • chloe zhouVerified

    Venture Capital · China

    Health CareHospitalsGeneticsEnterprise Software

    Portfolio: SeekGene, Microtech Medical

    Contact details available

  • Linda CaiVerified

    Venture Capital, Private Equity Firm · China

    Health CareGeneticsLife ScienceEmerging Markets

    Portfolio: InfiNovo, HYGEIA Healthcare Group

    Contact details available

  • Jay GuVerified

    Venture Capital, Private Equity Firm · China

    Health CareGeneticsLife ScienceEmerging Markets

    Portfolio: InfiNovo, HYGEIA Healthcare Group

    Contact details available

  • Brian Chi

    Private Equity Firm · China

    Health CareGeneticsLife ScienceBiotechnology

    Portfolio: InfiNovo, HYGEIA Healthcare Group

    Contact details available

  • Hao LiuVerified

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Rocen, Fenggu Xinxi

    Contact details available

  • Lisa Ye

    Private Equity Firm · China

    Health CareGeneticsLife ScienceBiotechnology

    Portfolio: InfiNovo, HYGEIA Healthcare Group

    Contact details available